# PROCHLORPERAZINE EDISYLATE

NDC: 43066-090
Generic name: prochlorperazine edisylate
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20210503

FDA application: ANDA214379

## Active ingredients

- PROCHLORPERAZINE EDISYLATE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43066-090"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43066-090
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=11cb37c7-01b4-4223-b2ea-a3695639b80b